First Time Loading...
N

Nuoncology Labs Inc
OTC:NLAB

Watchlist Manager
Nuoncology Labs Inc
OTC:NLAB
Watchlist
Price: 297 USD Market Closed
Updated: May 9, 2024

Nuoncology Labs Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nuoncology Labs Inc
Operating Income Peer Comparison

Comparables:
MEG
DMTK
SHC
SERA
S
SPEC

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
N
Nuoncology Labs Inc
OTC:NLAB
Operating Income
-$29.2k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Montrose Environmental Group Inc
NYSE:MEG
Operating Income
-$22.2m
CAGR 3-Years
N/A
CAGR 5-Years
-16%
CAGR 10-Years
N/A
DermTech Inc
NASDAQ:DMTK
Operating Income
-$103.7m
CAGR 3-Years
-43%
CAGR 5-Years
-142%
CAGR 10-Years
N/A
Sotera Health Co
NASDAQ:SHC
Operating Income
$276.7m
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Sera Prognostics Inc
NASDAQ:SERA
Operating Income
-$39.8m
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Spectaire Holdings Inc
NASDAQ:SPEC
Operating Income
-$7.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Nuoncology Labs Inc's Operating Income?
Operating Income
-29.2k USD

Based on the financial report for Dec 31, 2021, Nuoncology Labs Inc's Operating Income amounts to -29.2k USD.